QA: Monopar Therapeutics in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001645469_2020_Monopar_Therapeutics.pdf

Logs

info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001645469')"}

Graph

Absolute values for 0001645469, Monopar Therapeutics

  xvar xval
0 AssetsCurrent 13,229,640
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 122,381
4 LiabilitiesCurrent 724,165
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,355,243
9 ResearchAndDevelopmentExpense 1,968,518
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 98,887
13 remainder_ComprehensiveNetIncome -8,574
  yvar yval
0 Assets 13,352,021
1 Liabilities 724,165
2 Expenses 4,323,761
3 Revenues 0
4 StockholdersEquity 12,627,856
5 NetIncome -4,224,874
6 ComprehensiveNetIncome -4,229,161
7 BaseVar 9,253,704
8 EconomicCapitalRatio 2.49

Edgar->Model Mapping

Feature Distribution

Change over Time